formaldehyde has been researched along with aziridine in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (22.22) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nair, SP; Sen, AK | 1 |
| Besselaar, TG; Blackburn, NK | 1 |
| Dilovski, M; Tekerlekov, P | 1 |
| Dings, ME; Hulskotte, EG; Norley, SG; Osterhaus, AD | 1 |
| Brown, F | 1 |
| MILLER, Z | 1 |
| Barteling, SJ; Cassim, NI | 1 |
| Duan, K; Gao, S; Guo, M; Jiang, Y; Kang, H; Li, Y; Lian, G; Liu, M; Tang, L; Wu, Y; Yin, J | 1 |
| Bhanuprakash, V; Ganesh, K; Kishore, S; Sarkar, A; Tamil Selvan, RP | 1 |
1 review(s) available for formaldehyde and aziridine
| Article | Year |
|---|---|
Inactivation of viruses by aziridines.
Topics: Aziridines; Foot-and-Mouth Disease Virus; Formaldehyde; Humans; Poliovirus; Vaccines, Attenuated; Viral Vaccines | 2001 |
1 trial(s) available for formaldehyde and aziridine
| Article | Year |
|---|---|
[Comparative testing of the quality of foot-and-mouth disease vaccines prepared with different virus inactivators].
Topics: Aldehydes; Animals; Antibodies, Viral; Antiviral Agents; Aphthovirus; Aziridines; Clinical Trials as Topic; Epoxy Compounds; Formaldehyde; Quality Control; Sheep; Time Factors; Vaccines, Attenuated; Viral Vaccines | 1983 |
7 other study(ies) available for formaldehyde and aziridine
| Article | Year |
|---|---|
A study on the immune response of sheep to foot and mouth disease virus vaccine type 'O' prepared with different inactivants and adjuvants.
Topics: Adjuvants, Immunologic; Aluminum Hydroxide; Animals; Antibodies, Viral; Aphthovirus; Aziridines; Cattle; Cricetinae; Enzyme-Linked Immunosorbent Assay; Female; Foot-and-Mouth Disease; Formaldehyde; Guinea Pigs; Lanolin; Male; Mineral Oil; Neutralization Tests; Rabbits; Sheep; Time Factors; Vaccines, Inactivated; Viral Vaccines | 1992 |
A study of the effect of chemical inactivants on the epitopes of Rift Valley fever virus glycoproteins using monoclonal antibodies.
Topics: Animals; Antibodies, Monoclonal; Antiviral Agents; Aziridines; Enzyme-Linked Immunosorbent Assay; Epitopes; Formaldehyde; Glycoproteins; Propiolactone; Rift Valley fever virus; Vero Cells; Viral Envelope Proteins | 1991 |
Chemical inactivation of recombinant vaccinia viruses and the effects on antigenicity and immunogenicity of recombinant simian immunodeficiency virus envelope glycoproteins.
Topics: Animals; Aziridines; Cricetinae; Fixatives; Formaldehyde; Gene Products, env; Polymers; Rats; Simian Immunodeficiency Virus; Vaccines, Inactivated; Vaccines, Synthetic; Vaccinia virus; Viral Vaccines | 1997 |
Influence of the ethylenimine structure on the oxidation of choline, formaldehyde and sarcosine.
Topics: Aziridines; Choline; Formaldehyde; Glycine; Liver; Mechlorethamine; Nitrogen Mustard Compounds; Oxidation-Reduction; Oxidoreductases; Sarcosine; Triethylenemelamine | 1953 |
Very fast (and safe) inactivation of foot-and-mouth disease virus and enteroviruses by a combination of binary ethyleneimine and formaldehyde.
Topics: Animals; Antigens, Viral; Aziridines; Cattle; Cattle Diseases; Dose-Response Relationship, Immunologic; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Formaldehyde; Neutralization Tests; Treatment Outcome; Viral Vaccines | 2004 |
Effects of Three Types of Inactivation Agents on the Antibody Response and Immune Protection of Inactivated IHNV Vaccine in Rainbow Trout.
Topics: Animals; Antibodies, Viral; Antibody Formation; Aziridines; Blood; Disinfectants; Fish Diseases; Formaldehyde; Immunoglobulin M; Infectious hematopoietic necrosis virus; Mucus; Oncorhynchus mykiss; Propiolactone; Rhabdoviridae Infections; Survival Analysis; Vaccines, Inactivated; Viral Vaccines; Virus Inactivation | 2016 |
Comparison of different inactivation methods on the stability of Indian vaccine strains of foot and mouth disease virus.
Topics: Aziridines; Foot-and-Mouth Disease Virus; Formaldehyde; Glutaral; India; Vaccines, Inactivated; Viral Vaccines; Virus Inactivation | 2017 |